[DRBHCOM] YoY Annual (Unaudited) Result on 31-Mar-2010 [#4]

Stock
[DRBHCOM] DRB-HICOM BHD
Announcement Date
25-May-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2010
Quarter
31-Mar-2010 [#4]
Profit Trend
YoY- -28.49%
Quarter Report
Latest QR
Upcoming QR
DRBHCOM's Result
DRBHCOM's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Revenue 13,134,727 6,878,205 6,804,064 6,314,134 6,101,427 4,012,379 2,905,421 28.55%
PBT 1,037,367 1,821,399 701,524 657,894 774,943 376,073 187,131 32.99%
Tax -338,429 -146,791 -131,318 -114,629 -49,562 -24,344 -30,600 49.21%
NP 698,938 1,674,608 570,206 543,265 725,381 351,729 156,531 28.29%
-
NP to SH 575,305 1,596,920 472,468 472,298 660,507 292,395 95,073 34.95%
-
Tax Rate 32.62% 8.06% 18.72% 17.42% 6.40% 6.47% 16.35% -
Total Cost 12,435,789 5,203,597 6,233,858 5,770,869 5,376,046 3,660,650 2,748,890 28.57%
-
Net Worth 7,094,979 6,553,673 4,987,591 4,581,850 2,995,338 2,911,814 2,590,161 18.26%
Dividend
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Div 115,994 115,994 115,990 77,330 220,540 50,377 35,137 22.00%
Div Payout % 20.16% 7.26% 24.55% 16.37% 33.39% 17.23% 36.96% -
Equity
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Net Worth 7,094,979 6,553,673 4,987,591 4,581,850 2,995,338 2,911,814 2,590,161 18.26%
NOSH 1,933,237 1,933,237 1,933,175 1,933,270 1,393,180 1,007,548 1,003,938 11.52%
Ratio Analysis
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
NP Margin 5.32% 24.35% 8.38% 8.60% 11.89% 8.77% 5.39% -
ROE 8.11% 24.37% 9.47% 10.31% 22.05% 10.04% 3.67% -
Per Share
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
RPS 679.42 355.79 351.96 326.60 437.95 398.23 289.40 15.27%
EPS 29.76 82.60 24.44 24.43 47.41 29.02 9.47 21.00%
DPS 6.00 6.00 6.00 4.00 15.83 5.00 3.50 9.39%
NAPS 3.67 3.39 2.58 2.37 2.15 2.89 2.58 6.04%
Adjusted Per Share Value based on latest NOSH - 1,934,079
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
RPS 679.42 355.79 351.95 326.61 315.61 207.55 150.29 28.55%
EPS 29.76 82.60 24.44 24.43 34.17 15.12 4.92 34.94%
DPS 6.00 6.00 6.00 4.00 11.41 2.61 1.82 21.97%
NAPS 3.67 3.39 2.5799 2.37 1.5494 1.5062 1.3398 18.26%
Price Multiplier on Financial Quarter End Date
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Date 29/03/13 30/03/12 31/03/11 31/03/10 31/03/09 31/03/08 30/03/07 -
Price 2.53 2.52 2.30 1.16 0.69 1.27 1.95 -
P/RPS 0.37 0.71 0.65 0.36 0.16 0.32 0.67 -9.41%
P/EPS 8.50 3.05 9.41 4.75 1.46 4.38 20.59 -13.69%
EY 11.76 32.78 10.63 21.06 68.71 22.85 4.86 15.85%
DY 2.37 2.38 2.61 3.45 22.94 3.94 1.79 4.78%
P/NAPS 0.69 0.74 0.89 0.49 0.32 0.44 0.76 -1.59%
Price Multiplier on Announcement Date
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Date 30/05/13 29/05/12 26/05/11 25/05/10 28/05/09 29/05/08 30/05/07 -
Price 2.90 2.43 2.23 0.97 0.99 1.19 1.79 -
P/RPS 0.43 0.68 0.63 0.30 0.23 0.30 0.62 -5.91%
P/EPS 9.75 2.94 9.12 3.97 2.09 4.10 18.90 -10.43%
EY 10.26 33.99 10.96 25.19 47.89 24.39 5.29 11.66%
DY 2.07 2.47 2.69 4.12 15.99 4.20 1.96 0.91%
P/NAPS 0.79 0.72 0.86 0.41 0.46 0.41 0.69 2.27%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment